(Q30250349)

13 June 2017

0 references

1 reference

title

Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

13 June 2017

1 reference

1 reference

Poul Flemming Høilund-Carlsen

inferred from title

author

series ordinal

object named as

Poul Flemming Høilund-Carlsen

1 reference

13 June 2017

Poul Henning Madsen

1 reference

13 June 2017

Paw Christian Holdgaard

series ordinal

1 reference

13 June 2017

Janne Buck Christensen

series ordinal

1 reference

13 June 2017

publication date

11 May 2016

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

13 June 2017

1 reference

inferred from page(s)

published in

1 reference

13 June 2017

1 reference

13 June 2017

1 reference

13 June 2017

page(s)

2084-2097

1 reference

Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer

13 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

[Positron emission tomography 2013 in Germany. Results of the query and current status].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Death and dying: what the patient wants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Systematic reviews: synthesis of best evidence for clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

A typology of reviews: an analysis of 14 review types and associated methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Evidence summaries: the evolution of a rapid review approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Rapid review: an emerging approach to evidence synthesis in health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Rapid evidence assessment: increasing the transparency of an emerging methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

PET imaging in patients with bronchioloalveolar cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Positron emission tomography in staging early lung cancer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Preoperative staging of lung cancer with combined PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Delays in the diagnosis and treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Rapid needle-out patient-rollover approach after cone beam CT-guided lung biopsy: effect on pneumothorax rate in 1,191 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Partial-volume effect in PET tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Partial volume correction strategies for quantitative FDG PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Recent results of postoperative mortality for surgical resections in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

The pivotal role of FDG-PET/CT in modern medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3407-4

Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.

21 January 2018

1 reference

12 December 2020

Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer

1 reference

12 December 2020

LUCIS: lung cancer imaging studies

1 reference

12 December 2020

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

Head and neck incidentalomas on positron emission tomographic scanning: ignore or investigate?

1 reference

12 December 2020

18F-FDG PET/CT in the evaluation of adrenal masses.

1 reference

12 December 2020

Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance

1 reference

12 December 2020

Accuracy of PET/CT in characterization of solitary pulmonary lesions

1 reference

12 December 2020

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

12 December 2020

Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial

1 reference

12 December 2020

Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer

1 reference

12 December 2020

The role of FDG-PET/CT in detecting unsuspected and unknown distant metastasis in the initial staging of NSCLC.

1 reference

12 December 2020

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

1 reference

12 December 2020

Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT.

1 reference

12 December 2020

Air-space pattern in lung metastasis from adenocarcinoma of the GI tract

1 reference

12 December 2020

18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer

1 reference

12 December 2020

Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.

1 reference

12 December 2020

10.1007/S00259-016-3407-4

Identifiers

DOI

1 reference

13 June 2017

1 reference